简体中文
|
繁體中文
|
English
Home
News
Events
Media Services
About Us
About Interfax
Contact Us
Health and Pharmaceutical Press Releases
2019-06-12 09:48
Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance
2019-06-11 18:15
New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
2019-06-11 16:18
Microsure’s MUSA Microsurgery Robot Receives CE-mark
2019-06-11 15:59
Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
2019-06-11 10:01
Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®
2019-06-11 09:35
New post-hoc analysis shows consistent cardiorenal risk reductions of empagliflozin in a sub-group of adults with type 2 diabetes and chronic kidney disease without overt proteinuria
2019-06-10 14:53
Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial in AL Amyloidosis
2019-06-10 10:43
US FDA and EMA Accept Applications for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis
2019-06-06 17:54
Gavi, NEC, and Simprints to Deploy World’s First Scalable Child Fingerprint Identification Solution to Boost Immunization in Developing Countries
2019-06-06 17:51
Joe Kiani Named Honorary Academic by Mexican Academy of Surgery
2019-06-06 17:48
Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma
2019-06-06 14:00
Yokogawa Takes Strategic Stake in Finnish Company Sensire Ltd. to Pursue Collaboration in Cold Chain Monitoring
2019-06-06 10:06
Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG® (brigatinib)
2019-06-05 15:45
Ping An’s Healthtech Arm Cooperates with the Medical AI Lab Program of HKU
2019-06-04 19:46
Takeda Makes First Private Sector Pledge for Global Fund Replenishment
2019-06-04 09:57
New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase
2019-06-03 10:42
CureApp Announces Results from World’s First Randomized Control Study for Digital Therapeutic Smoking Cessation App
2019-05-31 20:17
WaveOptics and PEGATRON Demonstrate AiR Glasses Prototype at Both AWE and PEGATRON Day
2019-05-30 09:43
Qilu Pharmaceutical Expanding Biopharmaceutical Production Capacity with ABEC Bioreactor Systems
2019-05-29 18:45
Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
<< First
< Previous
173
174
175
176
177
178
179
180
181
182
Next >
Last >>
40849
40844
40842
40841
40833
40831
40818
40812
40807
40805
40804
40793
40794
40784
40774
40767
40757
40749
40716
40712
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2026-10-17 10:10
Chipscreen Biosciences Announces NMPA IND Approval for NW001, a PD-L1-Targeted Epigenetic Immune-Modulating Antibody Conjugate
2026-10-16 16:45
The Estée Lauder Companies Announces BEAUTY&YOU India 2026 Winners and Marks Five Years of Advancing Indian Beauty Entrepreneurship
2026-10-16 16:42
Introducing Ledger Atom™—Everything You Value, Finally Secure
2026-10-16 16:39
Andersen Global Deepens Private Client Tax Capabilities with KTA Tax
2026-10-16 16:35
Body of Waves, a New Artwork Only at teamLab Planets TOKYO, Unveiled